Temperature Controlled Pharma Packaging Market Japan's pharma industry boosts cold chain use for biologics, using advanced temp-controlled ...

Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies.

NEW JERSEY, NJ, UNITED STATES, May 26, 2025 /EINPresswire.com/ -- The global biosimilars market is experiencing robust growth as healthcare systems strive to improve patient access to life-saving ...

A recombinant protein therapy is produced through recombinant DNA technology, which involves inserting the DNA encoding the protein into bacterial or mammalian cells, expressing the protein in ...

It was also responsible for the first recombinant insulin product – Humulin – which launched in 1982 and remains on sale. Insulin products remain a multibillion-dollar business for the company ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

They may suggest insulin and eating adjustments, or technology to alert you overnight. Nocturnal hypoglycemia is the medical term for low blood sugar that happens while you sleep. While people ...

French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in Beijing, according to the Beijing Economic-Technological Development Area (BDA ...